SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-267921
Filing Date
2020-10-13
Accepted
2020-10-13 07:31:54
Documents
15
Period of Report
2020-10-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d11119d8k.htm   iXBRL 8-K 23442
2 EX-99.1 d11119dex991.htm EX-99.1 38248
6 GRAPHIC g11119g1010101129254.jpg GRAPHIC 2960
7 GRAPHIC g11119g1010101129457.jpg GRAPHIC 2348
  Complete submission text file 0001193125-20-267921.txt   202284

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgen-20201012.xsd EX-101.SCH 2719
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgen-20201012_lab.xml EX-101.LAB 18130
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgen-20201012_pre.xml EX-101.PRE 11377
8 EXTRACTED XBRL INSTANCE DOCUMENT d11119d8k_htm.xml XML 3321
Mailing Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021
Business Address 21823 30TH DRIVE SE SUITE BOTHELL WA 98021 4255274000
Seagen Inc. (Filer) CIK: 0001060736 (see all company filings)

IRS No.: 911874389 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32405 | Film No.: 201234598
SIC: 2836 Biological Products, (No Diagnostic Substances)